Financials
- Market Capitalization 359.28 M
- Employee 106
- Founded 2015
- CEO N/A
- Website www.foghorntx.com
- Headquarter Delaware, United States
- FIGI BBG00HFZPB88
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.58
ratio cours/chiffre d'affaires
11
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3148 | PALI Palisade Bio, Inc. - Common Stock | 2.11 USD | -0.94% | -0.94% | +4.46% | +24.12% | 367.71 M USD | ||
| 3159 | DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +0.75% | +2.58% | +1.35% | +15.58% | 364.00 M USD | ||
| 3177 | LYEL Lyell Immunopharma, Inc. - Common Stock | 14.61 USD | -1.28% | -6.47% | +13.26% | -39.60% | 358.02 M USD | ||
| 3189 | STRO Sutro Biopharma, Inc. - Common Stock | 20.60 USD | -3.33% | -5.03% | -13.15% | +18.46% | 341.57 M USD |